Search

everythinglearnresearchcommunity

for

Search:↓

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

A new compound effectively inhibits human 5α-reductase 1.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Upadacitinib improved multiple immune-related conditions in one patient.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

Upadacitinib effectively treats pyoderma gangrenosum.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Pranlukast and mirabegron may work as new diabetes drugs.